{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:12:34Z","timestamp":1782929554605,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008836","name":"Gaziantep University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["TF.UT.16.03"],"award-info":[{"award-number":["TF.UT.16.03"]}],"id":[{"id":"10.13039\/501100008836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cyto.2018.11.021","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T19:19:10Z","timestamp":1543000750000},"page":"116-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The relationship between visfatin and cardiac markers on induced myocardial infarction in rats"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-4568","authenticated-orcid":false,"given":"Mehmet","family":"Erten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130clal Geyikli","family":"\u00c7imenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuncay","family":"Kulo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kalayc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00fcsun","family":"Erten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.11.021_b0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","article-title":"Acute myocardial infarction","volume":"372","author":"White","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2018.11.021_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.disamonth.2012.12.004","article-title":"Acute myocardial infarction","volume":"59","author":"Boateng","year":"2013","journal-title":"Dis. Mon."},{"key":"10.1016\/j.cyto.2018.11.021_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bios.2015.03.037","article-title":"Diagnostics on acute myocardial infarction: cardiac troponin biomarkers","volume":"70","author":"Fathil","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.cyto.2018.11.021_b0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clinbiochem.2014.08.012","article-title":"The economics of cardiac biomarker testing in suspected myocardial infarction","volume":"48","author":"Goodacre","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cyto.2018.11.021_b0025","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Steuer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2018.11.021_b0030","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2004.06.071","article-title":"The quantification of infarct size","volume":"44","author":"Gibbons","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2018.11.021_b0035","first-page":"1","article-title":"Copeptin testing in acute myocardial infarction: ready for routine use?","volume":"2015","author":"Reinstadler","year":"2015","journal-title":"Dis. Markers."},{"key":"10.1016\/j.cyto.2018.11.021_b0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2018.11.021_b0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cyto.2018.11.021_b0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"91","author":"Chen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2018.11.021_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2362.2007.01904.x","article-title":"Increased plasma visfatin levels in subjects with the metabolic syndrome","volume":"38","author":"Filippatos","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cyto.2018.11.021_b0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1253\/circj.CJ-08-1169","article-title":"Endothelial dysfunction","volume":"73","author":"Vanhoutte","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.cyto.2018.11.021_b0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.metabol.2006.12.001","article-title":"Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus","volume":"56","author":"Takebayashi","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.cyto.2018.11.021_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/etm.2012.557","article-title":"Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus","volume":"4","author":"Uslu","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cyto.2018.11.021_b0075","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.4238\/2014.January.24.18","article-title":"An elevated plasma level of visfatin increases the risk of myocardial infarction","volume":"13","author":"Yang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.cyto.2018.11.021_b0080","doi-asserted-by":"crossref","first-page":"469852","DOI":"10.1155\/2012\/469852","article-title":"Increased expression of visfatin in monocytes and macrophages in male acute myocardial infarction patients","volume":"2012","author":"Chiu","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cyto.2018.11.021_b0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.peptides.2014.02.008","article-title":"Irisin: a potentially candidate marker for myocardial infarction","volume":"55","author":"Kuloglu","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.cyto.2018.11.021_b0090","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2018.11.021_b0095","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2018.11.021_b0100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.mpdhp.2012.09.001","article-title":"Pathology of myocardial infarction, coronary artery disease, plaque disruption, and the vulnerable atherosclerotic plaque","volume":"18","author":"Stone","year":"2012","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.cyto.2018.11.021_b0105","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.febslet.2006.06.052","article-title":"Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1","volume":"580","author":"Bae","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cyto.2018.11.021_b0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0030-1249059","article-title":"Effects of visfatin on proliferation and collagen synthesis in rat cardiac fibroblasts","volume":"42","author":"Yu","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cyto.2018.11.021_b0115","first-page":"688","article-title":"Elevated serum visfatin levels in patients with acute myocardial infarction","volume":"15","author":"Mazaherioun","year":"2012","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.cyto.2018.11.021_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2011.10.015","article-title":"Interpretation of elevated plasma visfatin concentrations in patients with ST-elevation myocardial infarction","volume":"57","author":"Lu","year":"2012","journal-title":"Cytokine"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:58Z","timestamp":1760907118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618304320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":24,"alternative-id":["S1043466618304320"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.11.021","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between visfatin and cardiac markers on induced myocardial infarction in rats","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}